Form 4: Johnson & Johnson Executive VP, CFO Joseph J. Wolk Reports Stock Option and Restricted Share Unit Awards

Executive VP and CFO of Johnson & Johnson, Joseph J. Wolk, reports the acquisition of stock options and restricted share units under the company's Long-Term Incentive Plan.

Summary

• Joseph J. Wolk, Executive VP and CFO of Johnson & Johnson, filed a Form 4 on February 19, 2025.
• The report details the acquisition of 91,277 employee stock options with an exercise price of $156.15, awarded under the Issuer's Long-Term Incentive Plan.
• These stock options vest in three equal annual installments starting February 15, 2026.
• Wolk also acquired 5,632 Restricted Share Units (RSUs) under the same plan.
• These RSUs also vest in three equal annual installments beginning February 15, 2026, and convert into common stock on a one-for-one basis upon vesting.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

• The granting of stock options and RSUs aligns executive compensation with the company's long-term performance.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the stock options and RSUs.

Industry Context

This type of equity compensation is standard practice for aligning executive incentives with shareholder value in large publicly traded companies like Johnson & Johnson.

Comparison to Industry Standards

• Equity compensation packages, including stock options and RSUs, are common among large pharmaceutical and healthcare companies such as Pfizer (PFE), Merck (MRK), and AbbVie (ABBV).
• The vesting schedules, typically three to four years, are also in line with industry norms to promote long-term commitment.
• The specific number of options and RSUs granted would be determined by Johnson & Johnson's compensation policies and the executive's role and performance.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align management's interests with long-term company performance.
• Employees may see this as a sign of the company's commitment to rewarding its executives.

Key Dates